Abstract. Xerostomia, the subjective sensation of oral dryness, and salivary gland hypofunction, the objective reduction of salivary flow, are common clinical findings with substantial implications for oral and general health. Although the two often coexist, they are distinct entities that do not always correlate. Reduced salivary output compromises the protective, digestive, and antimicrobial functions of saliva, predisposing patients to dental caries, candidiasis, mucosal discomfort, and diminished quality of life. This review summarizes the current understanding of the definitions, etiology, systemic associations, diagnosis, and management of xerostomia and salivary gland hypofunction, with particular attention to the medication-related and patient-population factors most relevant to everyday dental practice.
Definitions and Distinctions
It is clinically important to separate two related concepts. Xerostomia is a symptom — the patient’s perception of a dry mouth — and is assessed subjectively. Salivary gland hypofunction (hyposalivation) is a sign, defined by objectively measured reductions in unstimulated or stimulated salivary flow. A patient may report xerostomia with normal measured flow, or conversely demonstrate reduced flow without prominent symptoms, although symptoms commonly become apparent once unstimulated flow falls below roughly half of normal values. Recognizing this distinction guides both diagnosis and the interpretation of treatment response.
Etiology
The causes of reduced salivary function are diverse, but three categories dominate the literature. Medication use is the most frequent contributor: a large number of drug classes — including anticholinergics, antidepressants, antihypertensives, antihistamines, diuretics, and many others — reduce salivary output, and the effect is compounded by polypharmacy, making older adults especially susceptible. Head and neck radiotherapy can cause profound and frequently irreversible damage to salivary gland parenchyma, with severity related to radiation dose and field. Sjögren’s syndrome, a chronic autoimmune exocrinopathy, produces lymphocytic destruction of the salivary and lacrimal glands and is an important systemic cause to identify. Additional contributors include uncontrolled diabetes mellitus, dehydration, and certain chemotherapeutic agents.
Clinical Consequences
The loss of salivary protection has wide-ranging effects. Patients are at substantially increased risk of dental caries, classically in cervical and root surfaces and other sites less commonly affected when salivary flow is normal. Oral candidiasis and mucosal soreness or burning are common, as are dysgeusia (altered taste) and dysphagia. Reduced salivary lubrication also impairs the retention and comfort of removable prostheses. A systematic review of dental treatment outcomes has reported reduced restoration longevity and higher rates of recurrent caries in xerostomic patients, particularly those with Sjögren’s syndrome or a history of radiotherapy, underscoring the elevated restorative burden in this population. Collectively, these effects can meaningfully diminish oral-health-related quality of life.
Diagnosis
Assessment begins with a thorough history that explicitly reviews all medications and supplements, systemic conditions, and prior radiotherapy. Clinical examination may reveal a dry, sticky mucosa, a lobulated or depapillated tongue, scant or frothy saliva, and caries in atypical distributions. Objective evaluation through sialometry — measurement of unstimulated and stimulated flow rates — helps distinguish true hyposalivation from symptomatic xerostomia with preserved flow. When an autoimmune etiology such as Sjögren’s syndrome is suspected, serologic testing, salivary gland imaging, or minor salivary gland biopsy may be warranted, often in coordination with a physician or rheumatologist.
Management
Management is directed at identifying and, where possible, modifying the underlying cause, relieving symptoms, and preventing complications. When a medication is implicated, collaboration with the prescribing physician to adjust the agent, dose, or timing may be appropriate, though changes must always be made under medical supervision. Symptomatic and protective strategies include salivary stimulation with sugar-free gum or lozenges, topical saliva substitutes and moisturizing gels, and meticulous hydration. For patients with residual functional gland tissue, the systemic sialogogues pilocarpine and cevimeline can increase salivary flow in selected cases. Because caries risk is markedly elevated, intensive preventive measures — high-concentration topical fluoride, remineralizing agents, dietary counseling, and shortened recall intervals — are central to care. For a patient-oriented overview of these strategies, see our guide to dry mouth and how to find relief.
Conclusion
Xerostomia and salivary gland hypofunction are prevalent, frequently medication-related, and consequential for both oral and systemic health. Distinguishing the subjective symptom from objective glandular dysfunction informs accurate diagnosis, while management hinges on addressing the underlying etiology, relieving symptoms, and instituting aggressive caries prevention. Given the aging population and rising rates of polypharmacy, dental clinicians are well positioned to recognize these conditions early and to coordinate the multidisciplinary care that affected patients often require.
References
1. Plemons JM, Al-Hashimi I, Marek CL; American Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2014;145(8):867–873.
2. Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003;134(1):61–69.
3. Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2014;11:45–51.
4. Han P, Suarez-Durall P, Mulligan R. Dry mouth: a critical topic for older adult patients. J Prosthodont Res. 2015;59(1):6–19.
This article is intended for general educational purposes and does not constitute individual medical or dental advice. If you are experiencing persistent dry mouth, the team at Fridman Family Dental Care in Valencia, CA can help — contact us to schedule an evaluation.
